Sangam Health Care Products Ltd

BSE: 531625

6

total announcements

531625.BO · 15 min delayed

BSEAGM/EGMResults23h ago

Sangam Health Care Products Ltd

Scrutinzer Report

Sangam Health Care Products Ltd held its 32nd Annual General Meeting on September 30, 2026, where resolutions related to audited financial statements, director appointments, and reappointments were passed with majority votes.

Read more →📎 1 attachment
BSEAGM/EGMResults23h ago

Sangam Health Care Products Ltd

out come of 32nd Annual General Meeting

Sangam Health Care Products Ltd held its 32nd Annual General Meeting on September 30, 2026, where resolutions related to audited financial statements, director appointments, and other matters were passed with majority votes.

Read more →📎 1 attachment
BSEInsider Trading / SAST2d ago

Sangam Health Care Products Ltd

Closure of Trading Window

Sangam Health Care Products Ltd has announced the closure of its trading window from 1st October 2026, which will reopen after 48 hours from the declaration of unaudited financial results for the quarter and half year ending 30.09.2026.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change13 Aug 2026

Sangam Health Care Products Ltd

Re Appointment of Mr. Bhagat Reddy Dundumulla as Managing Director

Sangam Health Care Products Ltd has announced the reappointment of Mr. Bhagat Reddy Dundumulla as Managing Director for a further period of five years, subject to shareholder approval. The company has also announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 30.63 lakhs.

Read more →📎 1 attachment
BSEResultResults13 Aug 2026

Sangam Health Care Products Ltd

Financial Results for the quarter ended 30.06.2026

Sangam Health Care Products Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 30.63 lakhs. The company has also announced the reappointment of Mr. Bhagat Reddy Dundumulla as Managing Director for a further period of five years, subject to shareholder approval. The company's income from operations was Rs. 302.56 lakhs, and its expenses were Rs. 259.65 lakhs.

Read more →📎 1 attachment